Crossover Comparison of MultiHance and Dotarem

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study aims at a comparison between MultiHance at a dose of 0.1 mmol/kg and 0.05 mmol/kg and Dotarem at a dose of 0.1 mmol/kg in brain tumor patients to show superiority of MultiHance.
Epistemonikos ID: 23e3945b94b64f63e160c444f250fcbc945c8de5
First added on: May 11, 2024